Topics

Companies Related to "Karolinska Development publ Karolinska Development portfolio company Aprea" [Most Relevant Company Matches] RSS

08:41 EST 22nd November 2019 | BioPortfolio

Here are the most relevant search results for "Karolinska Development publ Karolinska Development portfolio company Aprea" found in our extensive corporate database of over 50,000 company records.

Showing "Karolinska Development publ Karolinska Development portfolio company Aprea" Companies 1–25 of 12,000+

Extremely Relevant

Karolinska Development and Aprea

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation Pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies; among the company's p...


Karolinska Development AB (publ), and BioChromix AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Karolinska Development AB PUBL

Managing one of the largest portfolios of life science research companies in Europe, Karolinska Development AB is a new type of company focused on filling the innovation gap within the pharmaceutical industry. Using a unique, highly cost-effective model Karolinska Development commercializes internationally renowned life science innovations, helping to deliver the medical products of the future...


Aprea AB

Aprea AB is a Swedish biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea's main shareholder is KDev Investments AB, an investment vehicle owned by Karolinsk...

Karolinska Development AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation Pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies; among the company's p...

Karolinska Development and Axelar

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation Pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies; among the company's p...

Karolinska Development AB and Axelar AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe. Using a unique business model, the company cost efficiently guides the commercialization of world class life science innovations. Since its inception in 2003, Karolinska Development has built a portfolio of some 40 companies. Among the company's projects, 12 candidate drugs are undergoing clinical...

Athera Biotechnologies AB

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two biopharmaceutical product candidates aimed at treating patients with acute heart conditions and a biomarker linked to the therapeutic approach. Athera is a Karolinska Development AB (publ) portfolio co...

Athera Biotechnologies & ALPCO

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two biopharmaceutical product candidates aimed at treating patients with acute heart conditions and a biomarker linked to the therapeutic approach. Athera is a Karolinska Development AB (publ) portfolio co...

Karolinska Development AB and Uminova Invest AB

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

PharmaSurgics AB and Karolinska Development AB

PharmaSurgics in Sweden AB is a Gothenburg based biotech company that develops and commercializes a novel treatment for preventing harmful scarring and promoting wound healing after surgery. PharmaSurgics product concept is based on proprietary synthetic peptides which have strong anti-inflammatory and anti-infectious properties. The company was founded in 2005, based on extensive research by ...

ACTAR AB

Actar is a biomedical company which builds the bridge from academic research to drug development. Actar is located at Karolinska Institutet and has eight employees. Actar identifies drug targets from Karolinska Institutet and other top Nordic Universities and performs drug development associated with the target to develop a candidate drug. The work is executed through high throughput screening of ...

Eribis Pharmaceuticals AB

Eribis Pharmaceuticals is focused on the development of novel drugs for the treatment of cardiovascular disorders, in particular acute myocardial ischemia, as well as surgical preconditioning. The company has unique competence in the development of peptides for pharmacological use. Eribis' novel peptide candidate drug represents a new drug category aimed at meeting the market need for new and ...

KAROLINSKA INVESTMENT FUND

KAROLINSKA INVESTMENT FUND is committed to generating superior capital returns for its investorsengages actively in defining goals and strategies to create attractive companies with globally demanded products invests in pharmaceutical, biotechnology and medical technology companies with a substantial commercial potential contributes with scientific, financial and industrial expertise and networks ...

Accuro Immunology AB

Accuro Immunology is a biomedical discovery company based at Karolinska Institutet in Stockholm, Sweden. Based on its proprietary TEIPP1 technology, Accuro develops active immunotherapies directed at escape variants of several cancers. The company has established preclinical proof-of-concept and is currently validating lead candidates for its clinical program. The company’s pipeline includes cel...

Karolinska Institutet

Karolinska Institutet is one of Europe's largest medical universities. It is also Sweden´s largest centre for medical training and research, accounting for 30 per cent of the medical training and 40 per cent of the medical academic research that is conducted nationwide. Karolinska Institutet´s mission is to improve the health of mankind through research, education and information.

Novum

A dynamic intellectual and international melting pot with open doors and natural interface between academia and industry. An environment which speaks of innovation, creativity and world-leading research expertise. Situated in Flemingsberg in southern Greater Stockholm, Novum is a daily meeting point for tens of thousands of students from the Karolinska Institute’s Huddinge Campus and Södertörn...

Relevant

Calabar AB

Calabar AB is a privately-held company committed to developing a pharmaceutical product addressing the great unmet needs of xerostomia "dry mouth". The company develops locally administered formulations of the cholinesterase inhibitor physostigmine, which has been shown to effectively increase salivary flow. Unlike systemically administered drugs, the local route of administration significantl...

Karocell Tissue Engineering AB

Karocell Tissue Engineering AB was started in 2001 based on research from the Karolinska Institute since the end of the 1980’s. It was founded by Professor Gunnar Kratz and Doctor Anders Boman to further develop their ideas within culturing of cells and tissue engineering. Tissue engineering, which is one of the fastest growing areas in medicine today, applies the principles of biology and engin...

RaySearch Laboratories

RaySearch’s business concept is to provide innovative software that creates more effective radiation therapy of cancer. The operations are predicated on the aim of improving people’s health and lives by shortening the time required for new scientific achievements in radiation therapy to be implemented in clinical use. The overall aim is to make RaySearch the leading supplier of advanced softwa...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology related to gene transfer and therapy and to serve as a professional adviser to the community and to the regulatory bodies in Europe.

Inbio Ltd.

Inbio Ltd is a biotechnology company based on Estonian private capital. Inbio was established by four leading biotechnology experts in Estonia in 1999. Located on campus of Tallinn Technical University Closely partnering with cancer drug discovery and development company Celecure Established academic multi-disciplinary skills base Team of 30 professionals including PhD-s from Oxford University,...

AngioGenetics AB

AngioGenetics is a Swedish biotechnology company focusing on discovery, development, and commercialisation of novel angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. AngioGenetics has developed solid platforms for drug and target discovery, and these provide a pipeline of novel lead compounds and use-patent protected drugs to fulfil industry deman...

Ore Pharmaceutical Holdings Inc.

Ore Pharmaceutical Holdings Inc. (the “Company”) is a pharmaceutical asset management company. The Company acquires interests in pharmaceutical assets whose value, it believes, it can significantly enhance through targeted development, with the goal of then monetizing these assets through sales or out-licensing transactions. The Company currently...

PhPlate AB

PhPlate Microplate Techniques AB produces and markets products that have been developed as a result of research going on at the Karolinska Institute, which is the medical university in Stockholm. The products produced and marketed by PhPlate are mainly microplate-based assays for typing/fingerprinting of bacteria (the PhenePlateTM system), and reagents for diagnostics of certain bacterial infectio...


More From BioPortfolio on "Karolinska Development publ Karolinska Development portfolio company Aprea"

Quick Search

Corporate Database Quicklinks